Brazikumab (Anti-IL-23)
Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn’s disease. MW: 144.82 KD.
| Trivial name | AMG 139; MEDI2070 |
| Catalog Number | A2965 |
| CAS# | 1610353-18-8 |
| Size | 1mg*25 |